How to buy Zimmer Biomet (ZBH) shares in Australia

Learn how to easily invest in Zimmer Biomet shares.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Zimmer Biomet Holdings Inc (ZBH) is a leading medical devices business with stocks listed in the US. It opened the day at US$150.39 after a previous close of US$150.4. During the day the price has varied from a low of USD149.185 to a high of USD151.725. The latest price was USD151.23 (25 minute delay). Zimmer Biomet is listed on the NYSE. All prices are listed in US Dollars.

How to buy shares in Zimmer Biomet

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Zimmer Biomet. Find the share by name or ticker symbol: ZBH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Zimmer Biomet reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$150.4, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Zimmer Biomet, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Zimmer Biomet. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Zimmer Biomet stock price (NYSE:ZBH)

Use our graph to track the performance of ZBH stocks over time.

Zimmer Biomet shares at a glance

Information last updated 2021-09-24.
OpenUS$150.39
HighUS$151.725
LowUS$149.185
CloseUS$151.23
Previous closeUS$150.4
Change US$0.83
Change % 0.5519%
Volume 1,657,789
Information last updated 2022-01-15.
52-week rangeUS$116.3796 - US$179.4704
50-day moving average US$127.6952
200-day moving average US$149.792
Target priceUS$162.73
PE ratio 32.5447
Dividend yield US$0.96 (0.75%)
Earnings per share (TTM) US$3.914

Where to buy Zimmer Biomet stock

Name Product Standard brokerage for US shares Currency conversion fee Markets
eToro (global stocks)
US$0
50 pips (US$0.50 for every AU$100 exchanged)
Global shares, US shares, ETFs
Zero brokerage share trading on US, Hong Kong and European stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
US$0
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
US$0
50 pips (US$0.50 for every AU$100 exchanged)
ASX shares, US shares, ETFs
Earn up to 15,000 Qantas frequent flyer points when you transfer an exisiting balance or trade. Offer valid for all new and existing Superhero members until 28 February.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
Saxo Capital Markets (Classic account)
US$4
1%
ASX shares, Global shares, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
SelfWealth (Basic account)
US$9.5
0.60%
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Zimmer Biomet stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Zimmer Biomet share growth calculator

US$

Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.

Zimmer Biomet price performance over time

Historical closes compared with the last close of $151.23

1 month (2021-12-17) 25.14%
3 months (2021-10-18) 4.32%
6 months (2021-07-19) 0.71%
1 year (2021-01-19) -5.44%
2 years (2020-01-17) 1.24%
3 years (2019-01-18) 43.56%
5 years (2017-01-19) 31.99%

Is Zimmer Biomet under- or over-valued?

Valuing Zimmer Biomet stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zimmer Biomet's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Zimmer Biomet's P/E ratio

Zimmer Biomet's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Zimmer Biomet shares trade at around 33x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Zimmer Biomet's PEG ratio

Zimmer Biomet's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.9165. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Zimmer Biomet's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Zimmer Biomet's EBITDA

Zimmer Biomet's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$2.4 billion (£1.7 billion).

The EBITDA is a measure of a Zimmer Biomet's overall financial performance and is widely used to measure a its profitability.

Zimmer Biomet financials

Revenue TTM US$7.9 billion
Operating margin TTM 16.67%
Gross profit TTM US$4.9 billion
Return on assets TTM 3.42%
Return on equity TTM 6.67%
Profit margin 10.39%
Book value 60.836
Market capitalisation US$26.6 billion

TTM: trailing 12 months

Zimmer Biomet's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Zimmer Biomet.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Zimmer Biomet's total ESG risk score

Total ESG risk: 40.16

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Zimmer Biomet's overall score of 40.16 (as at 12/31/2018) is pretty weak – landing it in it in the 77th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Zimmer Biomet is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Zimmer Biomet's environmental score

Environmental score: 9.29/100

Zimmer Biomet's environmental score of 9.29 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Zimmer Biomet's social score

Social score: 23.4/100

Zimmer Biomet's social score of 23.4 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Zimmer Biomet's governance score

Governance score: 16.46/100

Zimmer Biomet's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Zimmer Biomet is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Zimmer Biomet's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Zimmer Biomet scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Zimmer Biomet has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Zimmer Biomet Holdings Inc was last rated for ESG on: 2019-01-01.

Total ESG score 40.16
Total ESG percentile 77.24
Environmental score 9.29
Environmental score percentile 9
Social score 23.4
Social score percentile 9
Governance score 16.46
Governance score percentile 9
Level of controversy 2

Zimmer Biomet share dividends

13%

Dividend payout ratio: 12.75% of net profits

Recently Zimmer Biomet has paid out, on average, around 12.75% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.75% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Zimmer Biomet shareholders could enjoy a 0.75% return on their shares, in the form of dividend payments. In Zimmer Biomet's case, that would currently equate to about $0.96 per share.

While Zimmer Biomet's payout ratio might seem low, this can signify that Zimmer Biomet is investing more in its future growth.

Zimmer Biomet's most recent dividend payout was on 30 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 26 December 2021 (the "ex-dividend date").

Zimmer Biomet share price volatility

Over the last 12 months, Zimmer Biomet's shares have ranged in value from as little as US$116.3796 up to US$179.4704. A popular way to gauge a stock's volatility is its "beta".

ZBH.US volatility(beta: 1.25)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Zimmer Biomet's is 1.2458. This would suggest that Zimmer Biomet's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Zimmer Biomet overview

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site